Topic:Cannabidiol
Cannabidiol (CBD) is a non-psychoactive compound found in the cannabis plant, which has garnered interest for its potential applications in equine health. In horses, CBD is being explored for its effects on pain management, inflammation, and anxiety-related behaviors. Research is ongoing to understand the pharmacokinetics, safety, and efficacy of CBD in equine species. Studies focus on dosage, administration routes, and potential therapeutic benefits, as well as any adverse effects. This page compiles peer-reviewed research studies and scholarly articles that investigate the pharmacological properties, clinical applications, and regulatory considerations of cannabidiol in horses.
Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses. The increasing availability of cannabidiol (CBD) and anecdotal reports of its anti-inflammatory effects has garnered it much interest in the equine industry. The objectives of the current study were to (1) describe the pharmacokinetics of oral CBD in exercising thoroughbreds, (2) characterize select behavioral and physiologic effects, and (3) evaluate effects on biomarkers of inflammation using an ex vivo model. This study was conducted in a randomized balanced 3-way crossover design with a two-week washout period between doses. Horses received a single oral dose (0.5, 1, and 2 mg/kg) of CBD...
Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia. Growing evidence recognises cannabinoid receptors as potential therapeutic targets for pain. Consequently, there is increasing interest in developing cannabinoid receptor agonists for treating pain. As a general rule, to better understand the actions of a drug, it would be of extreme importance to know the cellular distribution of its specific receptors. The localisation of cannabinoid receptors in the dorsal root ganglia of the horse has not yet been investigated. Objective: To localise the cellular distribution of canonical and putative cannabinoid receptors in the equine cervical dorsal roo...
The endocannabinoid system modulates the ovarian physiology and its activation can improve in vitro oocyte maturation. The cannabinoid (CB) system has been involved in many aspects of reproduction and it is known that the systemic chronic use of exogenous CBs are deleterious to reproductive processes. Even so, it is not known what happens in relation to the physiology of the ovary when CB receptors are absent. The present study investigated the effect of the lack of CB1 and CB2 receptors in mice ovarian morphology, folliculogenesis, oocyte retrieval, and oocyte maturation and evaluated the use of Δ9-tetrahydrocannabinol (THC) on oocyte in vitro maturation (IVM) by comparing classical IVM and two-step IVM by a...
Effects of topical treatment of cannabidiol extract in a unique manuka factor 5 manuka honey carrier on second intention wound healing on equine distal limb wounds: a preliminary study. Evaluate the effect of topical 1% cannabidiol on second intention wound healing in distal limb wounds of horses. Methods: Experimental. Methods: Six Standardbred horses. Methods: A total of five 2.5 cm × 2.5 cm full thickness skin wounds were created on the dorsomedial aspect of the metacarpi of 6 horses. Wounds were contaminated with faeces on the day of wound creation. Each wound was then assigned to a treatment group; compounded 1% cannabidiol in unique manuka factor (UMF) 5 manuka honey, UMF 5 manuka honey, UMF 20 manuka honey or saline. Each treatment was applied topically daily ...
Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients. Osteoarticular equine disease is a common cause of malady; in general, its therapy is supported on steroids and nonsteroidal anti-inflammatories. Nevertheless, many side effects may develop when these drugs are administered. Nowadays, the use of new alternatives for this pathology attention is demanded; in that sense, cannabinoid CB2 agonists may represent a novel alternative. Cannabinoid belongs to a group of molecules known by their psychoactive properties; they are synthetized by the Cannabis sativa plant, better known as marijuana. The aim of this study was to contribute to understand the ...